PubRank

Shigekazu Takemura

Author PubWeight™ 72.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014 2.22
2 Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg 2002 2.00
3 Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004 1.48
4 Outcomes of hepatic resection for hepatolithiasis. Am J Surg 2009 1.26
5 Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatol Res 2007 1.13
6 Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 2010 1.12
7 Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2007 1.12
8 Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res 2003 1.08
9 Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World J Surg 2004 1.04
10 Calorie restriction improves cardiovascular risk factors via reduction of mitochondrial reactive oxygen species in type II diabetic rats. J Pharmacol Exp Ther 2006 1.01
11 Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan. J Hepatobiliary Pancreat Sci 2014 0.99
12 CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. Hepatogastroenterology 2004 0.95
13 Self-expanding metallic stent for benign biliary strictures: seven-year follow-up. Hepatogastroenterology 2004 0.94
14 Evaluation of the effect of portal vein embolization on liver function by (99m)tc-galactosyl human serum albumin scintigraphy. J Surg Res 2002 0.93
15 S-allyl cysteine attenuated CCl4-induced oxidative stress and pulmonary fibrosis in rats. Biofactors 2006 0.93
16 Nutritional risk index as an independent predictive factor for the development of surgical site infection after pancreaticoduodenectomy. Surg Today 2012 0.93
17 Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C. Hepatol Res 2004 0.92
18 Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett 2004 0.92
19 Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus. J Med Virol 2009 0.90
20 Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2012 0.90
21 Percutaneous transhepatic metallic stent placement for malignant portal vein stenosis. Hepatogastroenterology 2003 0.90
22 A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008 0.90
23 Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus. Liver Cancer 2013 0.89
24 Dietary nitrate inhibits stress-induced gastric mucosal injury in the rat. Free Radic Res 2003 0.88
25 Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma. World J Surg 2013 0.88
26 Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal Biochem 2008 0.86
27 S-allyl cysteine prevents CCl(4)-induced acute liver injury in rats. Free Radic Res 2007 0.85
28 Effect of AOB, a fermented-grain food supplement, on oxidative stress in type 2 diabetic rats. Biofactors 2007 0.85
29 Risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis. Hepatogastroenterology 2007 0.85
30 Adenomyoma of the common hepatic duct mimicking bile duct cancer: report of a case. Surg Today 2007 0.84
31 Generation of reactive oxygen species in sperms of rats as an earlier marker for evaluating the toxicity of endocrine-disrupting chemicals. Free Radic Res 2010 0.84
32 Surgical repair of a liver injury in a patient: accompanied with tricuspid regurgitation. Hepatogastroenterology 2003 0.84
33 Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2006 0.84
34 Local and systemic impacts of pleural oxygen exposure in thoracotomy. Biofactors 2007 0.84
35 Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases. Surg Today 2006 0.84
36 Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases. J Gastroenterol 2003 0.83
37 Risk factors for postoperative recurrence of non-B non-C hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2009 0.82
38 CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. Free Radic Biol Med 2004 0.82
39 Features and outcome after liver resection for non-B non-C hepatocellular carcinoma. Hepatogastroenterology 2012 0.82
40 The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 2011 0.82
41 Limy bile: a case of obstructive jaundice and review of 26 cases. Osaka City Med J 2003 0.82
42 Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway. Free Radic Res 2007 0.81
43 Usefulness of viral concentration measurement by transcription-mediated amplification and hybridization protection as a prognostic factor for recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatol Res 2003 0.81
44 Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Rep 2002 0.81
45 Nonoprerative management of obstructive jaundice caused by a benign hepatic cyst. Osaka City Med J 2004 0.81
46 Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer. J Gastroenterol Hepatol 2014 0.81
47 Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 2008 0.81
48 Supplementation of alpha-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type II diabetic rats. Free Radic Res 2008 0.81
49 Bile leakage after living donor liver transplantation demonstrated with hepatobiliary scan using 9mTc-PMT. Ann Nucl Med 2003 0.81
50 Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus. World J Surg 2003 0.80
51 Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Hepatogastroenterology 2004 0.80
52 Second hepatic resection for recurrent hepatocellular carcinoma in patients with chronic hepatitis C. World J Surg 2008 0.80
53 Convenience of a tape-guiding technique in different types of hepatectomy. Hepatogastroenterology 2008 0.80
54 Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer. J Hepatobiliary Pancreat Surg 2006 0.79
55 Reconstruction of hepatic veins by anastomosis with suprahepatic IVC in the posterior mediastinum in living donor liver transplantation for Budd-Chiari syndrome. Hepatogastroenterology 2009 0.79
56 Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006 0.79
57 Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004). Cancer Chemother Pharmacol 2014 0.79
58 Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2006 0.79
59 Splenic metastasis of hepatocellular carcinoma. Osaka City Med J 2006 0.79
60 Postoperative survival in intrahepatic cholangiocarcinoma showing intraductal growth. Hepatogastroenterology 2005 0.79
61 Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2012 0.78
62 Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 2004 0.78
63 Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Cancer Chemother Pharmacol 2014 0.78
64 Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy. J Hepatobiliary Pancreat Sci 2013 0.78
65 Changes in laboratory test results and diagnostic imaging presentation before the detection of occupational cholangiocarcinoma. J Occup Health 2014 0.78
66 Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 2005 0.78
67 Outcomes of Pure Laparoscopic versus Open Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients: A Case-Control Study with Propensity Score Matching. Eur Surg Res 2015 0.78
68 Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan. Hepatol Res 2005 0.78
69 Coadministration of carvedilol attenuates nitrate tolerance by preventing cytochrome p450 depletion. Circ J 2010 0.78
70 Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy. Surg Today 2007 0.78
71 Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol Res 2004 0.77
72 Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress. Free Radic Biol Med 2005 0.77
73 Limitation of portal vein embolization for extension of hepatectomy indication in patients with hepatocellular carcinoma. Hepatogastroenterology 2004 0.77
74 Long-term outcome of surgical treatment for ampullary carcinoma. Hepatogastroenterology 2012 0.77
75 Bowel injury associated with liver surgery for hepatocellular carcinoma. Hepatogastroenterology 2006 0.77
76 S-allylcysteine is effective as a chemopreventive agent against porcine serum-induced hepatic fibrosis in rats. Osaka City Med J 2009 0.77
77 Resection of needle-tract implantation after percutaneous puncture for hepatocellular carcinoma. J Gastroenterol 2004 0.77
78 Surgical treatment for intrahepatic cholangiocarcinoma. Clin J Gastroenterol 2014 0.77
79 Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score. J Gastroenterol 2005 0.76
80 High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study. World J Surg 2014 0.76
81 Organic nitrate tolerance is induced by degradation of some cytochrome P450 isoforms. Redox Rep 2002 0.76
82 Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC. Int J Clin Oncol 2008 0.76
83 Prognostic factors in patients with carcinoma of the papilla of Vater. Hepatogastroenterology 2002 0.76
84 Cytochrome P450 is responsible for nitric oxide generation from NO-aspirin and other organic nitrates. Drug Metab Pharmacokinet 2007 0.76
85 Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century. Surg Today 2014 0.76
86 Nicorandil elevates tissue cGMP levels in a nitric-oxide-independent manner. J Pharmacol Sci 2007 0.76
87 Minoxidil, a K(ATP) channel opener, accelerates DNA synthesis following partial hepatectomy in rats. Biofactors 2005 0.75
88 Continuous administration of organic nitrate decreases hepatic cytochrome P450. J Pharmacol Exp Ther 2003 0.75
89 Continuous treatment with organic nitrate affects hepatic cytochrome P450. Redox Rep 2004 0.75
90 Percutaneous management of bile duct injuries after cholecystectomy. Hepatogastroenterology 2002 0.75
91 [Cholangiocarcinoma developing in printing company workers: a new type of occupational cancer]. Gan To Kagaku Ryoho 2013 0.75
92 Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
93 Risk factors for intractable pleural effusion after liver resection. Osaka City Med J 2004 0.75
94 [Hepatic failure after liver resection in patients with cirrhosis]. Nihon Geka Gakkai Zasshi 2004 0.75
95 A case of glucagonoma at the uncinate process of the pancreas successfully treated by pancreaticoduodenectomy. Pancreas 2008 0.75
96 Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy. Am Surg 2017 0.75
97 [A case of a small intrahepatic cholangiocarcinoma treated with microwave coagulation therapy]. Nihon Shokakibyo Gakkai Zasshi 2005 0.75
98 Usefulness of biodegradable absorbable rib connecting pins in thoracoabdominal hepatectomy. Hepatogastroenterology 2003 0.75
99 [Intrahepatic cholangiocarcinoma associated with viral hepatitis]. Nihon Shokakibyo Gakkai Zasshi 2012 0.75
100 Pseudoaneurysm of the dorsal pancreatic artery with obstruction of the celiac axis after pancreatoduodenectomy: report of a case. Surg Today 2005 0.75
101 Fermented grain products, production, properties and benefits to health. Pathophysiology 2003 0.75
102 Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart. Osaka City Med J 2007 0.75
103 Type IV collagen 7s domain as a predictor of poor efficacy of portal vein embolization before major hepatectomy. Surg Today 2005 0.75
104 Amelioration of cisplatin toxicity by a fermented grain food product. Biofactors 2002 0.75
105 Two cases of intrahepatic cholangiocarcinoma detected after interferon therapy for chronic hepatitis C. Hepatogastroenterology 2005 0.75
106 Distant metastatic recurrence after hepatic resection for hepatocellular carcinoma. Osaka City Med J 2002 0.75
107 Curative resection of a huge bile duct cancer without pancreatoduodenectomy. Hepatogastroenterology 2004 0.75
108 Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma. World J Surg 2008 0.75
109 Polyamine metabolism and recurrence after resection for hepatocellular carcinoma. Hepatogastroenterology 2004 0.75
110 Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. Hepatogastroenterology 2015 0.75
111 FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation. Transplantation 2004 0.75
112 [A case of unresectable gastric cancer complicated by a serious hepatic disorder and Virchow lymph node metastasis in which FP therapy and TS-1 administration were effective]. Gan To Kagaku Ryoho 2002 0.75
113 Living-related liver transplantation in a patient with end-stage hepatolithiasis and a biliary-bronchial fistula. Hepatogastroenterology 2004 0.75
114 [Outbreak of cholangiocarcinoma developing in printing company workers : a new type of occupational cancer]. Nihon Shokakibyo Gakkai Zasshi 2014 0.75
115 A fermented grain food mixture, AOB, inhibits liver metastasis in the metastasis model of rat colon cancer. Biofactors 2004 0.75